6-N-(1H-benzimidazol-2-ylmethyl)-2-N-quinolin-6-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purine-2,6-diamine
C30H22F3N9 — CID 117090074
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-N-(1H-benzimidazol-2-ylmethyl)-2-N-quinolin-6-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purine-2,6-diamine
6-N-(1H-benzimidazol-2-ylmethyl)-2-N-quinolin-6-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purine-2,6-diamine (PubChem CID 117090074) has the molecular formula C30H22F3N9 and a molecular weight of 565.56 g/mol. Its IUPAC name is 6-N-(1H-benzimidazol-2-ylmethyl)-2-N-quinolin-6-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purine-2,6-diamine.
Molecular Properties
| Compound Name | 6-N-(1H-benzimidazol-2-ylmethyl)-2-N-quinolin-6-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purine-2,6-diamine |
|---|---|
| PubChem CID | 117090074 |
| Molecular Formula | C30H22F3N9 |
| Molecular Weight | 565.56 g/mol |
| Exact Mass | 565.20 |
| IUPAC Name | 6-N-(1H-benzimidazol-2-ylmethyl)-2-N-quinolin-6-yl-9-[[4-(trifluoromethyl)phenyl]methyl]purine-2,6-diamine |
| SMILES | FC(F)(F)c1ccc(Cn2cnc3c(NCc4nc5ccccc5[nH]4)nc(Nc4ccc5ncccc5c4)nc32)cc1 |
| InChI | InChI=1S/C30H22F3N9/c31-30(32,33)20-9-7-18(8-10-20)16-42-17-36-26-27(35-15-25-38-23-5-1-2-6-24(23)39-25)40-29(41-28(26)42)37-21-11-12-22-19(14-21)4-3-13-34-22/h1-14,17H,15-16H2,(H,38,39)(H2,35,37,40,41) |
| InChIKey | JNFCITOXQKZKPV-UHFFFAOYSA-N |
| XLogP | 6.67 |
| TPSA | 109.23 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 565.56 |
| LogP ≤ 5 | 6.67 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117090074 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.